Elevance Health (ELV) Depreciation & Amortization (CF) (2010 - 2019)

Elevance Health (ELV) has 10 years of Depreciation & Amortization (CF) data on file, last reported at $38.0 million in Q4 2019.

• On a quarterly basis, Depreciation & Amortization (CF) rose 18.75% year-over-year to $38.0 million in Q4 2019; TTM through Sep 2020 was $38.0 million, a 73.05% decrease from a year earlier, with the FY2025 full-year figure at $94.0 million, down 10.48% from the prior year.
• Depreciation & Amortization (CF) for Q4 2019 stood at $38.0 million, roughly flat from $38.0 million in the prior quarter.
• Over the last five years, Depreciation & Amortization (CF) for ELV reached as high as $38.0 million in Q3 2019 and fell as low as $25.1 million in Q1 2015.
• Historically, Depreciation & Amortization (CF) has averaged $29.6 million across 5 years, with a median of $27.8 million in 2015.
• Across the five-year window, Depreciation & Amortization (CF) decreased 6.67% in 2015 and gained 22.58% in 2019, its largest moves.
• Year by year, Depreciation & Amortization (CF) stood at $27.8 million in 2015, then slipped by 5.4% to $26.3 million in 2016, then climbed by 10.27% to $29.0 million in 2017, then gained by 10.34% to $32.0 million in 2018, then increased by 18.75% to $38.0 million in 2019.
• Per Business Quant data, the three most recent Depreciation & Amortization (CF) figures were $38.0 million in Q4 2019, $38.0 million in Q3 2019, and $37.0 million in Q2 2019.